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Abstract

Health centers are uniquely positioned to address the growing need for uniform clinical research
training, which leads to scientific advances in improving overall population health outcomes.
This study surveyed 44 clinical research professionals for their current baseline of research
competency and perceptions, within a single medical campus in Michigan, to obtain the current
baseline of education research competency for the suggested development and implementation
of a future clinical research training curriculum. Clinical study coordinators and senior staff
physicians accounted for 50% (22) of the survey respondents. Most of the participants 93% (41)
reported that the primary source of their research education was from on-the-job training. A
significant correlation was found between the self-reported level of understanding good clinical
practice (GCP) and the number of clinical trials supported. A larger sample size is warranted to
evaluate the impact of a formal research training program for clinical research professionals.
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Introduction
Clinical research education competency is integral to conducting clinical research that
yields high-quality results. Medical practice and clinical research function in unison to drive
therapeutic advances in treating medical conditions and delivering tomorrow’s therapeutic
breakthroughs. However, clinical research involves the use of investigational products that are
not approved by the U.S. Food and Drug Administration and require researchers to follow a
clinical investigational plan while complying with federal regulations and human subject
protection laws. Commonly, research medical ethics training, such as good clinical practice
(GCP) certification or human subject’s protection training are heavily relied on at research
institutions to encompass formal research training. Saleh et al. (2020) elaborate, “current GCP
training for investigators often uses a ‘one-size-fits all’ approach and lacks the practical and
pragmatic skills required to conduct clinical trials” (p.2). Clinical research coordinators
typically receive on-the-job training and learn as they go through trial and error to become
proficient in clinical research objectives (Behar- Horstein et al., 2018). In addition, these
professionals assume critical responsibilities central to the success of research team according
to Behar- Horstein et al. (2018). They go on to say, “the complexity of the research coordinator
role requires essential professional qualifications. One barrier to professionalization, however,
has been inconsistent, or absent, competency-based training” (p.2).
Sonstein and Jones (2018) state that the onboarding training of clinical research
coordinators is very minimal and poorly organized overall. They acknowledge most research
coordinators become skilled within their research role over time by gaining experience.
Furthermore, the responsibilities of their roles are in a dynamic state of change with increasing
technological or quality demands they add. Similarly, Sonstein and Jones (2018) note that as
new career opportunities
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arise clinical research professionals find themselves moving from the direction of proficient to
novice repeatedly. As clinical research designs continue to increase in complexity, so does the
support role of research professionals. However, Sonstein and Jones (2018) say that the lack of
professional requirements and solid foundation of research education knowledge can lead to role
dissatisfaction and personnel turnover as a costly by-product at health centers and impact the
overall progress of ongoing clinical research investigations.
The need for formalized clinical research guidance and the development of tools to
ascertain skills and competence is not limited to research coordinators. Physicians also struggle
with obtaining experience to proficiently lead as a principal investigator (PI), who oversees the
conduct of an entire clinical research protocol or participating as a sub-investigator and
understanding the requirements that are needed for clinical research care vs. standard medical
care for research patients (Saleh et al., 2020).
Residents and fellows are typically introduced to clinical research through direct
mentorships with senior staff physicians. A clinical research training perspective from medical
residents and fellows is warranted. Brubaker and Kenton (2011) state, and there is a research
education requirement for most programs. They go on to say for their residency program in
obstetrics and gynecology, many residents struggle with barriers to obtain effective clinical
research exposure. According to Brubaker and Kenton (2011), barriers to clinical research
include time conflicts for senior staff physicians, lack of desire to explore clinical research from
residents, financial restrictions, and lack of relevant outcome measures. In addition, they say a
common problem within research education is that residents are taught in a team format,
leaving residents to work on their own projects, such as retrospective chart reviews or to
collaboratively work on an existing project that is nearing completion. As a result, Brubaker
2

and Kenton (2011) say that by joining an existing team, the residents are not privy to the
formulation of establishing a formal research hypothesis and study design. They go on to say
that this may put residents at a future disadvantage for participating in clinical research or
possibly provide a negative connotation with clinical research that may lead the residents not to
participate in clinical research as a future clinician. Further development of formalized research
education for residents and fellows may be beneficial for improved research participation and to
have adequate knowledge on how to conduct future clinical research trials on his or her own.
Clinicians who have graduated from a fellowship program, may continue to obtain
additional education within research through an MD-Ph.D. program, which train physicianscientists in the career field of clinical care and research, but a decreasing number of physicians
are staying engaged in clinical research according to Sebastian et al. (2019). Mahmud et al.
(2018) further elaborate, “Physicians are a key human resource in conducting clinical trials”
(p.120). They go on to state, the engagement of physicians is paramount to ensuring the
successful conduct, quality of data collected, and completion of clinical trials.
Sebastian et al. (2019) and Mahmud et al. (2018) both identified common challenges that
physicians report in participating in clinical research, such as administrative burden of regulatory
paperwork, administering complex informed consent discussions, and securing protected
research time aside from their clinic schedule. Sebastian et al. (2019) suggest assessment tools
that measure self-efficacy within clinical research competencies may be useful to evaluate the
impact of research training programs to promote the development of clinical research skills in
future and current physicians who focus and participate in clinical research.
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Background
Refining existing training programs and developing new education and training
opportunities are essential for the continued success and invigoration of the current clinical
research work force according to Hornung et al. (2018). As evidenced by the guidance set forth
by the World Medical Association (2018) in the 2013 revision of the Declaration of Helsinki,
they go on to state, “Medical research involving human subjects must be conducted only by
individuals with the appropriate ethics and scientific education, training, and qualifications”
(p.2). An additional element to clinical research competency Hornung et al. (2018) mention is
the increasing complexity of clinical trial designs that are conducted in a real-world clinical
environment often with non-clinical research staff and with physicians that may lack formal
training in clinical research procedures.
As Hornung et al. (2019) elaborate, there is a critical need for tools to assess the quality
of established clinical research education programs that prepare individuals to enter the clinical
research profession and to measure continuing educational needs as clinical research
professionals’ careers evolve. However, until more recently, there was not an established
consensus within the clinical research industry for an agreed upon core competency skillset in
which, training requirements and continuing education for entry level candidates and seasoned
professionals would be based. Sonstein and Jones (2018) state during the spring of 2013, the
Joint Task Force (JTF) for Clinical Trial Competency and Clinical Research Professional
Workforce Development was formed through the collaboration of key opinion leaders in the
pharmaceutical industry, contract research organizations, academic institutions, clinical research
sites, and clinical research professional organizations.
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The JTF framework was developed to encompass a single global a set of professional
standards to serve as framework to define 51 professional core competences for clinical research
professionals (Sonstein & Jones 2018). There are eight domains within the JTF framework: “1.)
scientific concepts and research design; 2.) ethical and participant safety considerations; 3.)
medicines development and regulation; 4.) Clinical Trials Operations (GCPs); 5.) study and site
management; 6.) data management and informatics; 7.) leadership and professionalism; 8.)
communication and teamwork” (Hornung et al., 2018, p.47). According to Hornung et al.
(2018), that in 2015, the National Center for Advancing Translational Sciences (NCATS) at the
National Institutes of Health expanded upon the JTF core competencies introducing Enhancing
Clinical Research Professionals Training and Qualification (ECRPTQ). Behar-Horstein et al.
(2018) remark that the goal of the ECRPTQ was to implement a standardized training process
for translational clinical research leading to the advancement of training and qualification
strategies that could be applied across research institutions in the setting of academic health
centers in substitution of on-the-job training only.
Currently, about 40% of investigators are dropping out of clinical trial responsibilities
while the number of clinical research investigators in North America are decreasing compared to
the number of investigators in Europe (Saleh et al., 2020). As a result, Saleh et al. (2020) theorize
that clinical research trials are being led by less investigators, which has the potential to impact
the overall compliance and integrity of clinical trial outcomes. In addition, they found that failure
to follow the clinical investigational plan was found to be the most common FDA audit
deficiency in 51% of inspections in clinical trials from 2004 to 2011. To address the
shortcomings of current investigator clinical research training, they developed a course for
hands-on training called the Clinical Investigator Program (CITP). Moreover, Saleh et al. (2020)
developed the CITP with the
5

hypothesis that, in order to increase quality and quantity of clinical research investigators it is
essential to train junior faculty by providing clinical research education instruction to motivate
them to become responsible investigators.
The curriculum of the CITP took the eight domains of clinical research competency
created by the JTF into account for development of their clinical research training program for
senior fellows and new junior faculty physicians (Saleh et al., 2020). As evidenced by the
experience gained from clinical residency and fellowship training, a similar set-up was proposed
for clinical research education through the mentorship of pairing of experienced physicians with
new research investigators to gain insight into practical applications they mention.
According to Saleh et al. (2020), the CITP had the following goals: (a) to provide a
general overview of the rationale of clinical research protocols and responsibilities of the PI,
(b) introduce the concepts of the site activation process for clinical trials and clinical trial
management, and (c) enlighten investigators to existing institutional support or research and
mechanisms to benchmark the timeline of opening a clinical research trial. A pre-test and
post-test were administered to participants to measure knowledge gained from the 2-month
course. Positive feedback was generated from the CITP program; however, Saleh et al. (2020)
convey there remains an unmet need for addressing practical aspects of clinical research
education without prolonged time commitment away from physicians’ clinical schedules to
sufficiently prepare investigators for the role of a PI.
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Purpose of the Study
This study aims to investigate emerging research professional education needs within an
urban Michigan hospital by surveying research staff members regarding their current
competency and perceptions of research education. The research questions were as follows:
Research Question 1: Does the self-reported knowledge of GCPs increase with the number of
clinical research trials supported by clinical research staff?
Research Question 2: Is there a significant difference in the understanding of the necessary
operational steps of clinical research when comparing the education level of clinical
researchers with associate degrees vs. master’s and doctoral degrees?

7

Methods
A survey was developed to determine the current research education needs at the urban
hospital with input from senior staff physicians, coworkers, and an experienced advisor at
Eastern Michigan University (EMU). The survey consisted of 22 questions. Furthermore, the
questions were grouped into the domains of demographics, basic research experience, and selfperceived assessments of clinical research knowledge. A small group of colleagues volunteered
to pilot test the survey as part of the survey development process to ensure the questions were
clear and could be answered through the web based online survey platform SurveyMonkey. The
experienced advisor and student researcher ensured that all items on the EMU survey
development checklist were satisfied prior to distributing the survey to the participants.
The survey sample size of 50 respondents was approved by the institutional review board
at the urban hospital under the Thesis Committee Member Ding Wang, MD, PhD, and the
graduate student as a co-investigator (Appendices A and B). The health system approval letter
has been de-identified to protect the confidentiality of the institution. The survey then was
submitted along with the graduate school survey development checklist (Appendix C) and
approved by the University Human Subjects Review Committee at EMU (Appendix D). The
research was classified as exempted under research category 2(i) as anonymous survey research
in which, no direct identifiers and no indirect identifiers, such as IP address were collected to
ensure the identity of the survey participants could not be ascertained. The study was designed to
evaluate the perception of current research education knowledge among research staff within an
urban hospital setting.
After obtaining both human ethics committee approvals for this study, permission to use
an internal email distribution listserv that represented the population was granted. The survey
was distributed through Survey Monkey and emailed to clinical research staff members in
8

December 2020. To participate in this study, participants had to agree to the study terms listed in
the de-identified informed consent script (Appendix E) by clicking “I agree” if participants did
not agree to participate in the survey, a program algorithm was applied after a participant
selected “I do not agree” to direct participants to a survey exit page.
Data Analysis
Data collected from the survey was downloaded from Survey Monkey into an Excel
spreadsheet format. Questions of interest were uploaded to Statistical Package for Social
Sciences (SPSS) Premium v27 and categorized into nominal data. Responses from select survey
questions were grouped for correlative data analysis. The alpha level used for all tests of
significance was α = 0.01. Pearson’s two-tailed correlations were explored to determine if there
was a relationship between the variables.
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Results
The survey conducted included an analysis of 44 individuals that agreed to participate.
The response rate of the survey was 88%. All 50 participants selected “I agree to participate”,
but six did not continue to complete the rest survey questions for unknown reasons. According
to this survey, 28 (63.6%) of the participants were female and 16 (36.4%) were males. Current
job titles at the health system were reported as the following: 11 (25%) were senior staff
physicians, 11 (25%) were clinical study coordinators, 7 (15.9%) clinical research nurses, 7
(15.9%), 4 (9.1%) research grant/contract specialists, 2 (4.6%) research managers, 1 (2.3%)
fellow physician, and 1 (2.3%) research assistant. The most frequently reported highest degree
level completed by the participants was a bachelor’s degree 15 (34.1%) followed by second
highest reported degree level of a doctoral degree in medicine 11 (25%). Detailed results of the
population demographics are presented in Table 1.
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Table 1
Demographic Characteristics of Survey Participants
Gender
Current Job
Title

Highest Degree
Level
Completed

Females
Males
Senior staff physician
Fellow physician
Nurse manager
Research manager
Clinical research nurse
Clinical study coordinator
Research assistant
Research grant/contract specialist
Other:
Data manager
Physician assistant
Medical lab assistant
Nurse practitioner
Clinical pharmacy specialist
IRB/regulatory coordinator
Medical office coordinator/Fibroscan

n = 28 (63.6%)
n= 16 (36.4%)
n = 11 (25%)
n = 1 (2.3%)
n=0
n = 2 (4.6%)
n = 7 (15.9%)
n = 11 (25%)
n = 1 (2.3%)
n = 4 (9.1%)
n = 7 (15.9%)
n=1
n=1
n=1
n=1
n=1
n=1
n=1

Associate’s degree
Bachelor’s degree
Master’s degree
Doctoral degree (MD)
Doctoral degree (PhD)
Doctoral degree (MD, PhD)
Other:
Medical assistant
Doctor of Pharmacy (Pharm D)

n = 4 (9.1%)
n = 1 (34.1%)
n = 9 (20.5)
n = 11 (25%)
n = 2 (4.6%)
n = 1 (2.3%)
n = 2 (4.5%)
n=1
n=1
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Of the 44 participants who responded to the question, 14 (31.8%) reported spending
between 31 and 40 hours a week on average participating in clinical research. Likewise, 12
(27.3%) participants reported spending 41 hours or more per week supporting clinical research
trials. If applicable to their job position, survey participants were asked how many clinical trials
total did they enroll patients on within the last year: 8 (18.2%) of participants reported enrolling
15 or more patients on a clinical trial within the last year, and 18 (40.9%) reported it was not
applicable to their clinical research role. A detailed summary of the additional survey responses
to these questions are presented in Table 2.
Table 2
Survey Respondents Clinical Trial Participation
Average hours per
week spent
participating in
clinical research

1-10
11-20
21-30
31-40
41 or more
Number of clinical
Less than 5
trials supported
1-10
11-20
21-30
31 or more
Number of patients
1-4
enrolled within the last 5-9
year
10-14
15 or more
Not applicable to
my role

n = 8 (18.2%)
n = 6 (13.6%)
n = 4 (9.1%)
n = 14 (31.8%)
n = 12 (27.3%)
n = 9 (18.2%)
n = 5 (11.4%)
n = 11 (25%)
n = 4 (9.1%)
n = 16 (36.4%)
n = 7 (15.9%)
n = 7 (15.9%)
n = 4 (9.1%)
n = 8 (18.2%)
n = 18 (40.9%)
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Figure 1 details how survey participants obtained their current knowledge of research
education. The majority of the survey respondents 93.2% (41) reported that they obtained their
current knowledge of research education through on-the-job training (job shadowing, protocol
specific training by research sponsors), or Collaborative Institutional Training Initiative (CITI)
(GCP) training. An additional 27.3% (12) participants obtained their current clinical research
education through professional certification, specifically Certified Clinical Research Professional
(CCRP) or Association of Clinical Research Professionals (ACRP). Additional mechanisms of
obtaining current clinical research education included an advanced medical degree (MD or DO)
20.5% (9), a graduate degree with a concentration in clinical research 4.6% (2), and 2.3% (1)
held an undergraduate degree with a concentration in clinical research. Other options for
obtaining current knowledge of clinical research education were selected by 9.1% (4) of the
respondents and can be found in Appendix F.
Figure 1
Self-reported Mechanisms for Obtaining Clinical Research Knowledge

Mechanisms of Research Education
Other

9.1
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20.5
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0

20
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Survey respondents were asked to rate their current knowledge of GCP. According to the
World Health Organization (2002) International Council for Harmonization of Technical
Requirements for Pharmaceuticals for Human Use, GCP is an international ethical and scientific
quality standard for the design, conduct, performance, monitoring, auditing, recording, analysis,
and reporting of clinical trials and serves to protect the rights, integrity, and confidentiality of
human subjects. The survey found that 95% of the participants reported having an acceptable or
better knowledge of GCPs. Specifically, 50% (22) of participants stated they had a “good”
knowledge of GCPs, 34% (15) reported that they had a “very good” understanding, and 11.4%
(5) said their knowledge was acceptable (Figure 2).

Figure 2
Participants Self-reported Knowledge of GCPs

Self-reported Rating of GCP Knowledge
2.3

2.3

11.7
34.1

50

Very Good

Good

Acceptable

14

Poor

Very poor

Participants were asked to rate their current understanding of all the necessary steps that
are required to be executed prior to opening a clinical research trial to patient enrollment (i.e.,
site selection, institutional review board (IRB) approval, finalized contact and budget, and site
initiation visit). They were instructed to choose the option that best represented their knowledge
on a scale from 1 = very poor to 5 = very good. Most participants (66.3%) rated their current
understanding of clinical trial operations as being “good” or “very good” (Figure 3).
Figure 3
Survey Participant’s Reported Understanding of Clinical Research Operations
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The survey question “in your opinion, what is your interpretation of the term ‘physician
investigator’ in which, a physician writes a protocol and conducts his or her own clinical
research investigation?” was included as a comprehension question to see if respondents were
aware of the correct U.S. Food and Drug Administration (FDA) definition. Over half of the of
the participants 56.8% (25) selected the correct response (Option d. an individual who both
initiates an investigation, and under whose direct supervision an investigational product is
dispensed). The additional options for the question (Figure 4) included (a) writing a clinical
trial protocol and designating research responsibilities as appropriate to clinical and
administrative staff, (b) receiving U.S. Food and Drug Administration (FDA) or institutional
review board (IRB) approval of a research protocol along with obtaining funding to execute
the clinical research investigation, or (c) overseeing a clinical investigation that is financed by
pharmaceutical company support.
Figure 4
Reported Self-Reported Interpretation of the Term “Physician Investigator”

Interpretation of the Term Physician Investigator
60

Percentage

50
40
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0
a.

b.

c.
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d. Correct answer

Participants were asked about their experience with the FDA Investigational New Drug
(IND) application process. Most of the participants >75% reported they had no knowledge of the
IND application process or that the process does not apply to their research role. Only 20.5% (9)
of the participants reported being somewhat experienced from obtaining IND approval for one
prior clinical trial (Figure 5).
Figure 5
Reported Experience with the FDA IND Application Process
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In addition, participants were asked to self-report how knowledgeable they considered
themselves about the FDA’s expanded access program. According to the U.S. FDA (2020)
expanded access is a program in which, an IND is granted by the FDA as a potential pathway for
a patient with an immediately life-threatening condition or serious disease or condition to gain
access to an investigational medical product (drug, biologic, or medical device) for treatment
outside of clinical trials when no comparable or satisfactory alternative therapy options are
available. More than half of the participants 60% (27) self-reported that they were
“knowledgeable” or “somewhat knowledgeable” about the expanded IND access program while
31.8% (14) of respondent’s reported that they did not consider themselves knowledgeable
(Figure 6).
Figure 6
Participants-Reported Knowledge About the Expanded Access IND Process

Reported Knowledge for Expanded Access IND
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If applicable to their clinical research role, participants were asked if they had been
previously granted approval for an expanded access IND, and if so, they were asked how many
IND’s total. A limited number of survey participants 15 (2.9%) responded that this question
was applicable to his or her research role and they had received at least one approval for an
expanded access IND. All survey responses to this question can be viewed in Appendix G.
Survey participants were asked to self-report how comfortable they felt regarding their
knowledge of understanding of statistical methods, for clinical research design and analysis.
The respondents 40.9% (18) reported they did not feel comfortable with their current
understanding of statistical analysis methods and 38.6% (17) self-reported they were somewhat
comfortable. Only 20.5% (9) of participants reported they were comfortable with their current
understanding of statistical methods. None of the survey participants reported that they were
very comfortable with their current level of understanding (Figure 7).
Figure 7
Participants Self-Reported Comfort Level for Understanding Statistical Analysis
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Similarly, when participants were asked to self-report how confident they felt about their
current understanding of resources to obtain clinical research funding if applicable to their
research position, 40.9% (18) of the participants reported that they were not confident in their
current understanding. Methods for obtaining research funding was not applicable to 29.6% (13)
of the respondents. Only 4.6% (2) of the participants self-reported they were very confident in
their understanding of research funding mechanisms and 25% (11) that rated themselves as
confident (Figure 8).
Figure 8
Participants Self-Reported Confidence for Obtaining Clinical Research Funding
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Participants were asked to select all applicable clinical research aspects that they would
like to improve their current overall understanding of. Of the survey respondents, 59.1% (26)
indicated they would like to improve their understanding of statistical analysis methods for
clinical research, and 50% (22) stated they would like to improve their understanding of clinical
trial funding and budget development. In addition, 47.7% (21) of participants stated they would
like to improve their overall understanding of U.S. FDA and IRB requirements for the regulatory
approval of clinical research studies. Additional response options included 38.6% (17)
manuscript development, 38.6% (17) clinical research study coordination, 25% (11) knowledge
of a letter of intent, and 15.9% (7) requirements for posting studies on ClinicalTrials.gov (Figure
9).
Figure 9
Participants Reported Interest for Future Clinical Research Education Opportunities
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Survey participants were asked for feedback on research supportive services within the
health system to facilitate future clinical trial opportunities. A large number of the participants
59.1% (26) indicated more regulatory support was needed for clinical trial opportunities.
Interestingly, research nurse support, clinical study coordinator support, and quality assurance
and internal auditing program were all equally tied with 57.3% (23) for each option respectively.
Almost half of the participants 47.8% (21) believed finance and budgeting services were
important to facilitate clinical trial opportunities. Medical writing services, 34.1% (15);
statistical support services, 31.8% (14); and posting and managing studies on ClinicalTrials.gov,
15.9% (7), were viewed as less of a priority to support future research opportunities (Figure 10).

Figure 10
Opportunities for Improvement in Clinical Research Support Services
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Participants were asked to select all options that applied regarding current barriers to their
clinical trial participation and for others that performed a similar job to them. Time constraints
with clinic schedule, 61.4% (27); burden of required clinical trial paperwork/administrative
regulatory requirements, 56.8% (25); and lack of support from management for opportunities to
participate in clinical research 31.8% (14) were the top three current barriers to clinical research
participation. A complete summary of all responses can be seen in Figure 11. Responses
recorded as “other please specify” can be found in Appendix H.

Figure 11
Current Barriers to Clinical Research Participation Within the Health System
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Participants were asked how likely the current experience of the COVID-19 pandemic
would challenge the future of clinical trial operations (i.e., continued use of remote site initiation
visits, remote monitoring visits, telemedicine for research patient visits, and administrative
research staff working remotely from home). Most of the participants 75% (33) believed it was
“likely” or “very likely” that the COVID-19 pandemic would change the future of clinical trial
operations while only 4.5% (2) believed it was not likely that future operations would be
impacted (Figure 12).
Figure 12
Participants Response to the Experience of the Ongoing COVID-19 Pandemic
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Survey respondents were asked to rank what clinical research career development
resources they would be interested in, if offered by the health system, on a scale from 1 to 4 (1 =
most interested and 4 = least interested). A clinical research professional focused seminar series
was the most requested career development resource that participants were interested in with
40.9% (18) of the responses. Participants equally ranked the following career development
resources, respectively, with 36.4% (16) of responses for each option: formal clinical trials
mentorship program, increase in the number of annual clinical trial workshops offered for
physician investigators, and greater exposure to clinical research during fellowship programs
(Figure 13).
Figure 13
Ranked Interest of Clinical Research Career Development Resources
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The final survey question was optional and allowed for an open-ended response from
participants to comment on additional clinical trial career resources that were not previously
listed in Question 21. Twenty-three participants answered this question, and twenty-seven
participants skipped this question. The recorded responses can be viewed in Appendix I.
Statistical Analysis

Research Question 1: Does the Self-reported Knowledge of GCPs Increase With the Number of
Clinical Research Trials Supported by Clinical Research Staff?
A statistically significant correlation was found between the number of clinical trials
supported by research staff and the self-reported knowledge of GCPs (r = .428, p < 0.1; Table
3).
Research Question 2: Is There a Significant Difference in the Understanding of the Necessary
Operational Steps of Clinical Research, When Comparing the Education Level of Clinical
Researchers With Associate Degrees vs. Master’s and Doctoral Degrees?
No statistically significant relationships were found when comparing the education level
(associate’s, bachelor’s, master’s, or doctoral degree) and self-reported understanding of clinical
trials operational steps (Table 4).
The correlation between the self-reported understanding of all required clinical trials
operational steps and knowledge of GCPs was explored and revealed a statistically significant
negative correlation (r = -.395, p < 0.1; Table 5).
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Table 3
Correlation Between Number of Clinical Trials Supported and GCP knowledge

Clinical trials supported

Pearson Correlation
Sig. (1-tailed)
N

Good Clinical Practice (GCP) knowledge
.428**
.004
44

Table 4
Correlation Between Education Level and Understanding Clinical Trial Steps
Associates degree
Understanding necessary steps

Pearson Correlation
Sig. (1-tailed)
N

Understanding necessary steps

Pearson Correlation
Sig. (1-tailed)
N

Bachelors degree
.064
.340
44

Masters Degree

.145
.173
44
Doctoral Degree

-.009
.477
44

Table 5
Correlation Between Understanding Necessary Clinical Trial Steps and GCP Knowledge

Understanding necessary steps

Pearson Correlation
Sig. (1-tailed)
N

Good Clinical Practice (GCP) knowledge
-.395**
.008
44
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-.055
.362
44

Discussion
The purpose of this study was to identify emerging research education needs within
clinical research staff in an urban hospital setting and to obtain a baseline of current research
competency. The study results confirmed that a statistically significant (r = .428) relationship
exists between self-reported knowledge of GCPs and number of clinical trials supported by the
research staff. Meaning, as the number of clinical trials supported increases, the self-reported
knowledge of GCPs also increases. These results confirm the primary endpoint of this study and
indicates the survey participants gain further understanding of GCPs as they participate in more
clinical trials. No significant relationship was found between the reported level of education of
the survey participants and understanding all necessary operational steps of a clinical trial.
When the relationship between reported understanding of all the necessary clinical trial
operation steps and knowledge of GCPs was explored, this revealed a statistically significant
negative correlation. Only 36.6% (16) of participants responded that their knowledge of all
operational aspects was “good.” However, when participants were asked to self-rate their
knowledge of GCPs, 50% (22) of the survey population reported their knowledge as “good.” The
self-reported scales for both questions were skewed in a positive direction and in addition, the
sample size for this question was small leading to a negative correlation when the relationship
between the variables was analyzed.
More female participants 63.6% (28) responded to the survey than male participants
36.4% (16). Clinical study coordinators and senior staff physicians accounted for 50% (22) of the
survey respondents. The most frequently reported highest level of education was a bachelor’s
degree 34.1% (15). Only 27.3% (12) of the participants reported that they had obtained a
professional certification in clinical research.
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Participants largely reported that the source of their research education was from “on the
job training” or by obtaining a secondary professional certification in clinical research.
Therefore, the primary reported source of research education is through informal job training.
As Sonstein and Jones (2018) note, this has created research professionals to need experience to
obtain a job and a professional certification, but employment is needed to obtain job experience
and professional certification. However, it should be noted a clinical research professional
certification program requires applicants to have at least two years, of previous research
employment to be eligible for a certification examination, as it is assumed that experience
equates with research education competence.
The results showed that 31.8% (14) researchers reported spending at least 40 hours per
week on research and, in some cases, 27.2% (12) of the respondents reported they spend more
than 40 hours per week on clinical research. Approximately, 36.6% (16) participants reported
supporting 31 or more clinical trials. Enrolling patients was not applicable to most of the
participants research role, and 40.9% (18) of the survey participants that did not have a direct
clinical role. A question for future studies that may be investigated is how many years of
experience a research professional may have as this variable was not measured in this study.
Although a question was included within this survey regarding current years of research
experience, there was an oversight in transposing this question into the Survey Monkey
platform’ therefore, this data was not collected.
The survey responses concluded 40.9% (18) of respondents reported they were not
comfortable with their current knowledge of statistical methods for clinical research design.
Similarly, over half of the survey of the survey population, 59% (26), responded that
statistical analysis methods for clinical research was the top item that they would like to
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improve their overall understanding of. In addition, 50% (22) of the survey respondents said
they were not confident in their current understanding resources to obtain research funding or
to develop a clinical research budget. Both items should be considered as content for future
research education training workshops.
The survey results indicated that 47.7% (21) of respondents would like to improve their
current understanding of FDA and IRB requirements for the approval of clinical research studies.
These findings coincide with many of the respondents not having any experience with the FDA
IND approval process 36.4% (16) or no previous knowledge about the FDA expanded access
IND process 31.82% (14). There is a need for the future development of educational content
regarding the regulatory requirements that need to be fulfilled in order to obtain FDA and IRB
approval.
Respondents were asked what currently existing research services at the health system
could be improved to facilitate clinical trial opportunities. The top-reported choice respondents
felt could be improved was regulatory support services at 59.1% (26). The second highest
reported supportive service in need of improvement were tied with 52.3% (23) for each option
respectively: clinical study coordinator support, research nurse support, and quality assurance
and internal auditing program. Participants may have chosen these two items as clinical trials are
dependent upon the support of adequate research personnel to obtain regulatory approval and
maintain study records. In addition, study coordinator support is critical for the enrollment and
care of research patients. Quality assurance evaluates the performance of both clinical research
professional roles. Perhaps the survey population thought there was an indirect relationship
regarding the oversight of quality assurance feedback and productivity of study coordinator and
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regulatory support services. Interestingly, participants did not feel that finance/budgeting
services or statistical support services needed improvement.
The survey found the top three current barriers to participation within clinical research
for participants were time constraints with clinic schedule, 61.4% (27); burden of required
clinical trial paperwork/administrative regulatory requirements, 56.8% (25); and lack of support
from management for opportunities to participate within clinical research, 31.8% (14). These
findings are comparable to existing literature sources that have conducted similar survey studies
of research professionals within a hospital setting. Caldwell et al. (2017) performed a study of 26
research participants to identify barriers to participation in research within a regional cancer
center in the United Kingdom. They found that the respondents reported a lack of required
knowledge, skills and training, support from managers, and a lack of time or opportunity to be
involved in research. Hillyer et al. (2020) also found within their study that clinical trial
paperwork was reported as barrier to clinical trial participation. In contrast, this study found
difficulty in communicating complex information was only reported to be a barrier by 15.9% (7)
of respondents, whereas Hillyer et al. (2020) found that 57.1% (56) found communication with
patients to be a barrier to clinical research participation.
This study had some limitations. First, the sample size for this study was relatively small
and limited conclusions can be drawn from the data generated. Second, most of the survey
responses were obtained from study coordinators and senior staff physicians leading to
interpretation of the results through the lens of a limited group of research professionals. Lastly,
the survey population is only inclusive of responses from one medical campus in the state of
Michigan; therefore, it is not representative of the general academic research staff population
and their exposure to clinical research education.
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However, the survey results of this study have identified the current baseline of clinical
research education knowledge and self-reported levels of confidence within the urban hospital
setting. In addition, respondents have offered insight into the preferred format of future
educational opportunities, such as a formal clinical trials mentorship program, greater exposure
to clinical research during fellowships, and a clinical research professional focused seminar
series. Feedback has also been obtained for clinical research supportive services that the
respondents feel could be improved at the health system outside of the immediate clinical
research education
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Conclusions
The study findings conclude that no relationship was found between the level of
education completed and the reported self-assessment of understanding of all the necessary
clinical trial steps that need to be completed in order to open a research study to patient
enrollment, and there was a significant correlation between the level of self-reported GCP
knowledge and the number of clinical trials supported. A larger sample size is needed to draw
definitive conclusions.
Future development of a research education curriculum addressing the identified
knowledge gaps as a result of this survey is warranted. This study found that participants desired
to improve their understanding of statistical methods for clinical research design and analysis;
mechanisms of obtaining clinical trial funding, including budgeting; and requirements for FDA
and IRB approval. The research education needs identified in this study can be used as a baseline
comparison for future research educational assessments of research professionals upon the
implementation of a clinical research training program.
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Appendix B: Survey
Clinical Research Education and Perceptions Survey

1.
a.
b.
c.
d.
e.
f.
g.
h.
i.

What is your current job title?
Senior staff physician
Fellow physician
Clinical study coordinator
Research assistant
Research manager
Nurse manager
Clinical research nurse
Research grant/contract specialist
Other

2. What is the highest degree level that you have completed?
a. Associates degree
b. Bachelor degree
c. Master’s degree
d. Doctoral degree (MD)
e. Doctoral degree (PhD)
f. Doctoral degree (MD/PhD)
3.
a.
b.
c.
d.

What gender do you identify as?
Male
Female
Other
Prefer not to say

4.
a.
b.
c.
d.
e.
f.

How many total years of clinical research experience do you have?
Less than one year
1-5 years
6-10 years
11-15 years
16-20 years
21 or more

5. How many hours a week on average do you estimate that you participate in clinical research? Choose
the option that best represents you.
a. 1-10 hours
b. 11-20 hours
c. 21-30 hours
d. 31-40 hours
e. 41 or more
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6. How many clinical trials do you currently support? Please choose one option.
a. Less than 5
b. 1-10
c. 11-20
d. 21-30
e. 31 or more
7. Within the last year, how many clinical trials did you enroll patients on?
a. 1-4
b. 5-9
c. 10-14
d. 15 or more
e. Not applicable to my role
8. By what method, have you obtained your current knowledge of clinical research? Select all that
apply.
a. “On the job” training (Job shadowing, protocol specific training by research sponsors, or CITI GCP
training)
b. Professional certification (Certified Clinical Research Professional or Association of Clinical Research
Professionals)
c. Undergraduate concentration in clinical research
d. Graduate degree with a concentration in clinical research
e. Medical advanced medical degree (MD or DO)
f. Other
9. How would you rate your current understanding of all the necessary steps that are required to be
executed, prior to opening a clinical research trial to patient enrollment? (e.g. site selection, institutional
review board (IRB) approval, finalized contract and budget, and site initiation visit).
Choose the option that best represents your knowledge.
(1= Very poor, 5= Very good)
a. 1
b. 2.
c. 3
d. 4
e. 5
10. In your opinion, what is your interpretation of the term “physician investigator” in which, a physician
writes a protocol and conducts his or her own clinical research investigation? Please choose one option.
a. Writing a clinical trial protocol and designating research responsibilities as appropriate to clinical and
administrative staff
b. Receiving U.S. Food and Drug Administration (FDA) or Institutional Review Board (IRB) approval of a
research protocol along with obtaining funding to execute the clinical research investigation
c. Overseeing a clinical investigation that is financed by pharmaceutical company support
d. An individual who both initiates and conducts a clinical investigation, and under whose direct
supervision an investigational product is administered or dispensed
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11. Which, of the following clinical trial aspects would you like to improve your overall understanding
of? Choose all that apply.
a.
b.
c.
d.
e.
f.
g.
h.

Knowledge of a letter of intent
FDA and Institutional Review board requirements for study approval
Statistical analysis methods for clinical research
Mechanisms for clinical trial funding and budget development
Manuscript development
Requirements for posting studies on ClinicalTrials.gov
Clinical research study coordination
Other

12. What is your experience with the FDA Investigational New Drug (IND) application process? Choose
the best option that represents your experience.
a.
b.
c.
d.
e.

Very experienced, I have been granted approval of an IND by the FDA three or more times
Somewhat experienced, I have obtained IND approval for at least one clinical research trial
I have only treated a patient on an expanded access (compassionate use) IND
I have no experience with the IND approval process
Does not apply to my research position

13. The FDA defines the term “expanded access” Investigational New Drug application (IND) as a
potential pathway for a patient with an immediately life-threatening condition or serious disease or
condition to gain access to an investigational medical product (drug, biologic, or medical device) for
treatment outside of clinical trials when no comparable or satisfactory alternative therapy options are
available.
How knowledgeable would you consider yourself about this process? Please choose one option.
a. Very knowledgeable
b. Knowledgeable
c. Somewhat knowledgeable
d. Not knowledgeable

14. If you have been previously granted approval for an expanded access IND, how many IND’s total
have you received approval for?
a.
b. Not applicable

15. How comfortable are you overall in your understanding of statistical methods for clinical research
design and analysis? Please choose one option.
a. Very comfortable
b. Comfortable
c. Somewhat comfortable
d. Not comfortable
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16. How confident are you in your understanding of resources to obtain research funding? Please
choose one option.
a. Very confident
b. Confident
c. Somewhat confident
d. Not confident
e. Not applicable
17. Good Clinical Practice (GCP) is an international ethical and scientific quality standard for the design,
conduct, performance, monitoring, auditing, recording, analyses and reporting of clinical trials. GCP also
serves to protect the rights, integrity and confidentiality of human subjects.
In your opinion, how would you rate your current knowledge of GCPs? Please choose one option.
a.
b.
c.
d.
e.

Very good
Good
Acceptable
Poor
Very poor

18. What research supportive services do you feel could be improved to facilitate clinical trial
opportunities within the health system? Select all that apply.
a.
b.
c.
d.
e.
f.
g.
h.

Regulatory support services
Clinical study coordinator support
Research nurse support
Finance/budgeting services
Statistical support services
Medical writing services
Posting and managing studies on Clinicaltrials.gov
Quality assurance and internal auditing program

19. In your opinion, what are the current barriers to participation within clinical research for you and
others that do a similar job to you? Select all that apply.
a.
b.
c.
d.
e.
f.
g.

Time constraints with clinic schedule
Burden of required clinical trial paper work/administrative regulatory requirements
Lack of support from management for opportunities to participate in clinical research
Difficulty in communicating
Limited knowledge base to participate
Limited funding opportunities
Other
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20. Will the experience of the COVID-19 pandemic will challenge the future of clinical trial operations?
(e.g. remote site initiation visit, remote monitoring visits, and continued use of telemedicine for
research patient visits, and research administrative staff working remotely from home). Please choose
one option.
a. Very likely
b. Likely
c. Somewhat likely
d. Not likely
21. What clinical research career development resources would you be interested in, if offered by the
health system? Please rank the options on a scale from 1 to 4 with 1 =being the most interested and 4=
being the least interested.
a. Formal clinical trials mentorship program
b. Greater exposure to clinical research during fellowship programs
c. Clinical research professional focused seminar series
d. An increase in the amount of annual clinical research workshops offered for physician investigators
22. Are there any other clinical trial career resources you would be interested in that not mentioned
above?
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Appendix C: EMU Survey/or Interview Development Checklist
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Appendix D: Exempt Approval Letter EMU Human Subjects Review Committee

Dec 8, 2020 3:23:48 PM EST
Francesca Picotte
Eastern Michigan University, School of Health Sciences
Re: Exempt - Initial - UHSRC-FY20-21-122 A Survey of Clinical Research Education and Perceptions Among Research Staff within
an Urban Hospital Setting
Dear Francesca Picotte:
The Eastern Michigan University Human Subjects Review Committee has rendered the decision below for A Survey of Clinical
Research Education and Perceptions Among Research Staff within an Urban Hospital Setting. You may begin your research.
Decision: Exempt
Selected Category: Category 2.(i). Research that only includes interactions involving educational tests (cognitive, diagnostic,
aptitude, achievement), survey procedures, interview procedures, or observation of public behavior (including visual or auditory
recording).
The information obtained is recorded by the investigator in such a manner that the identity of the human subjects cannot readily be
ascertained, directly or through identifiers linked to the subjects.
Renewals: Exempt studies do not need to be renewed. When the project is completed, please contact human.subjects@emich.edu.
Modifications: Any plan to alter the study design or any study documents must be reviewed to determine if the Exempt decision
changes. You must submit a modification request application in Cayuse IRB and await a decision prior to implementation.
Problems: Any deviations from the study protocol, unanticipated problems, adverse events, subject complaints, or other problems
that
may affect the risk to human subjects must be reported to the UHSRC. Complete an incident report in Cayuse IRB. Follow-up:
Please contact the UHSRC when your project is complete.
Please contact human.subjects@emich.edu with any questions or concerns.
Sincerely,
Eastern Michigan University Human Subjects Review Committee

45

Appendix E: Survey Monkey Consent Script

46

Appendix F: Question 1---Other Responses for Obtaining Current Knowledge of
Research Education

Response
MBBS from India
Academic Journals; Undergraduate nursing
focusing in interpreting and implementing
evidence-based practice.

n
1
1

Readings from professional publications,
active clinical trial protocols and conferences

1

14 years as a clinical trials coordinator in a
different department

1
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Appendix G: Question 14---Other Responses

Total Reported Number of IND’s
Approved
Former job at KCI
1
15+
3
One, but I was on the upfront of the approval.
Someone else managed the patient once they
applied for access
4
2
2
1
3
2-5
1
1
2
1

n
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
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Appendix H: Question 19---Other Barriers to Participation in Clinical Research

Other Response
Limited portfolio of available studies

n
1

My job is solely based in trials participation. I
have no barriers, nor do my colleagues that
hold the same role
In ability to get physicians to help find
patients. Also, in in patient studies
cooperation of those physicians to have time
or make time to inform us if they have a
patient that might fit one of the inpatient
studies.
Workload
Fear of mistakes and resultant regulatory
issues due to lack of personnel to support
trials at Clinical Trial Office

1

For our department it is more of a lack of staff
and our PIs wanting to take on everything and
anything rather than what we can
accommodate at the time
I feel that there is not a well-rounded
understanding of clinical trials amongst all
staff. They see what they do, and not the big
picture of the office, or how it will affect
someone 10-15 years down the road when a
drug is FDA approved.
Staffing
Short staff

1

1

1
1
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1

1
1

Appendix I: Question 22---Open-ended Responses for Career Resources

Response
None/No/Not applicable
A culture of clinical research needs to be
developed by aligning incentives and
facilitating the activity - research RVUs have
been considered but difficult to deploy and
value

n
18
1

1
I have been a member for SWOG, NRG
Oncology, serving as physician investigator,
attend group meetings, especially serving as
committee member to support the inter-group
clinical trial operations have help myself in
clinical trials as continued learning/education,
as well as clinical trials operation
1
Understanding and providing a physician
compensation model that promotes clinical
research
Formal on the job training
1
Free ACRP certification and paid membership 1
fees by institution
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